Brain+ fully on track towards market entry and first sales in the United Kingdom in H2 2024
NEWS RELEASE Copenhagen, Denmark, 23 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ is executing in full alignment with its Market Access plan for the CST-Assistant in the United Kingdom (UK), having met several milestones to date in 2024 · Additional UK-related key milestones in view for Q3 include validation of the Clinical Evaluation Report for the CST-Assistant, final results from the Age UK usability study, and full UK Medical Device certification · Brain+ retains its expectations of the release of the CST-Assistant as a UK Medical-Device-Software